View Clinical Trial (Medical Research Study)
Continuous Positive Airway Pressure (CPAP) Titration and Treatment Versus Auto-adjusting Positive Airway Treatment for Sleep Apnea - NCT00988351-32608(Clinical Trial 368136)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Gainesville |
|
State:
|
|
FL |
| Zip Code: |
|
32608 |
| Conditions: |
|
Obstructive Sleep Apnea |
| Purpose: |
|
The purpose of this randomized prospective study is to compare the efficacy of two
approaches to initiate PAP treatment in patients diagnosed as having OSA by portable
monitoring (limited sleep study). One pathway involves attended CPAP titration by PSG (full
attended sleep study) followed by CPAP treatment. The other pathway involves treatment with
auto-adjusting positive airway pressure (without a titration). Study Aims: Compare PAP
adherence, improvement in subjective sleepiness (Epworth Sleepiness Scale), reaction time
(Psychomotor vigilance test), quality of life by the Functional Outcomes of Sleep
Questionnaire (FOSQ), and PAP satisfaction (PAP satisfaction questionnaire) between the two
study arms.
|
| Study summary: |
|
RESEARCH PLAN: All patients being evaluated for possible OSA are required to attend a Sleep
Education and Evaluation Class before having a sleep study. At this class they receive
information on sleep apnea, PAP treatment, and the types of sleep studies. They also
complete a sleep questionnaire to identify co-existing sleep disorders and important
co-morbid medical conditions. Screening of the sleep questionnaire and the patient's
medical record is part of routine care to identify patients needing a diagnostic PSG and/or
an attended titration. At the end of the class, participation in the current study will be
offered the patients. Those signifying interest in being part of the research study and
meeting inclusion and exclusion criteria will be contacted to participate in the study.
Once they sign an informed consent they will be randomized to one of the two clinical
pathways.
METHODS: Study visits:
Before informed consent (routine clinical care)
1. Sleep Education and Evaluation Class (education about OSA, sleep studies, and OSA
treatment). Patients complete screening sleep and medical history questionnaires.
2. Determination of patient interest in participating in the current study and review of
inclusion/exclusion criteria
After informed consent
1. PM study
2. Randomization if the PM study is diagnostic of OSA. If not, the patient will be
offered a diagnostic PSG. If this is positive, they will have APAP treatment. If both
the PM and PSG are negative for OSA the patient exits the study but will be followed in
sleep clinic.
3. PSG for CPAP titration (PSG arm only).
4. CPAP/APAP setup - patient fills out ESS and Functional Outcomes of Sleep Questionnaire
(FOSQ) and performs psychomotor vigilance testing (PVT). The same Research
coordinator/Respiratory therapist will setup the units, fit masks, and instruct the
patients on the use of their device. Patients being treated with CPAP or APAP will be
in separate classes.
5. Telephone contact within 7 days of setup with early intervention for PAP problems if
needed.
6. Clinic visit 6 weeks after starting treatment: download objective adherence, ESS, FOSQ,
PVT, and PAP satisfaction questionnaire. |
| Criteria: |
|
Inclusion Criteria:
- OSA, Apnea-hypopnea index > 5/hour
Exclusion Criteria:
- Prior CPAP
- Uncontrolled Depression
- Moderate to Severe COPD
- Hypoventilation
- Average estimated nightly total sleep time < 4 hours
- Shift work
- Unstable depression
- Upper airway surgery
- Uncontrolled RLS, narcolepsy
- Use of supplemental oxygen
- Severe congestive heart failure
- Use of nightly potent narcotics
- Severe obesity (BMI > 40) |
|
|
|
| Study is available at: |
|
Malcom Randall VA Medical Center Gainesville, FL 32608 United States
Primary Contact: Richard B Berry, MD Email: berryrb@medicine.ufl.edu Phone: 352-262-1575
Secondary Contact: Richard B Berry, MD Email: berryrb@medicine.ufl.edu Phone: 3522621575 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 23, 2011 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|